Publicaties

2020

Moekotte AL, Malleo G, van Roessel S, Bonds M, Halimi A, Zarantonello L, Napoli N, et al. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. Br J Surg. 2020 Apr 7. doi: 10.1002/bjs.11555. [Epub ahead of print]

Stoop TF, Scholten L, Besselink MG; Dutch Pancreatic Cancer Group. Author response to: Comment on: Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg. 2020 Apr;107(5):618

Strijker M, Mackay TM, Bonsing BA, Bruno MJ, van Eijck CHJ, de Hingh IHJT, Koerkamp BG, van Laarhoven HW, et al. Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group. Ann Surg. 2020 Apr;271(4):e102-e104. doi: 10.1097/SLA.0000000000003779. No abstract available

Overbeek KA, Cahen DL, Kamps A, Konings ICAW, Harinck F, Kuenen MA, Koerkamp BG, Besselink MG, van Eijck CH, et al. Dutch Familial Pancreatic Cancer Surveillance Study Group. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance.Fam Cancer. 2020 Mar 19. doi: 10.1007/s10689-020-00171-8. [Epub ahead of print]

Van Dongen JC, Smits FJ, van Santvoort HC, Molenaar IQ, Busch OR, Besselink MG, Aziz MH, Groot Koerkamp B, van Eijck CHJ; Dutch Pancreatic Cancer Group. C-reactive protein is superior to white blood cell count for early detection of complications after pancreatoduodenectomy: a retrospective multicenter cohort study. HPB (Oxford). 2020 Mar 11. pii: S1365-182X(20)30055-1. doi: 10.1016/j.hpb.2020.02.005. [Epub ahead of print] 

Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, et al. Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. Of download deze publicatie als PDF. J Clin Oncol. 2020 Feb 27:JCO1902274. doi: 10.1200/JCO.19.02274. [Epub ahead of print].

Latenstein AEJ, van Roessel S, van der Geest LGM, Bonsing BA, Dejong CHC, Groot Koerkamp B, de Hingh IHJT, et al. Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model. Ann Surg Oncol. 2020 Feb 12. doi: 10.1245/s10434-020-08235-w.

2019

Latenstein AEJ, van der Geest LGM, Bonsing BA, Groot Koerkamp B, et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 2019 Dec 13;125:83-93.

Scholten L, Latenstein AEJ, van Eijck C, Erdmann J, et al. Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study. Surgery. 2019;166(6):1017-1026.

Scholten L, Stoop TF, Del Chiaro M, Busch OR, et al. Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg. 2019;106(13):1735-1746.

Klompmaker S, de Rooij T, Koerkamp BG, Shankar AH, et al. International Validation of Reduced Major Morbidity After Minimally Invasive Distal Pancreatectomy Compared With Open Pancreatectomy. Ann Surg. 2019 Oct 17. [Epub ahead of print]

Linnemann RJA, Patijn GA, van Rijssen LB, Besselink MG, et al. The role of abdominal drainage in pancreatic resection – A multicenter validation study for early drain removal. Pancreatology. 2019;19(6):888-896.

Dijkgraaf MG, van Hilst J, Bossuyt PM, Besselink MG. The harms of early cessation of trials on systematic reviews – Authors’ reply. Lancet Gastroenterol Hepatol. 2019;4(9):667-668.

Mackay TM, Smits FJ, Roos D, Bonsing BA, et al. The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis. HPB (Oxford). 2019 Aug 19. pii: S1365-182X(19)30610-0.

Huang L, Jansen L, Balavarca Y, van der Geest L, et al. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study. Ann Surg. 2019 Aug 13. doi: 10.1097/SLA.0000000000003558. [Epub ahead of print].

Smits FJ, Molenaar IQ, Besselink MG, Borel Rinkes IHM, et al. Early recognition of clinically relevant postoperative pancreatic fistula: a systematic review. HPB (Oxford). 2019 S1365-182X(19)30619-7.

Van Veldhuisen E, van den Oord C, Brada LJ, Walma MS, et al. Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies. Cancers (Basel). 2019 Jul 12;11(7).

Smits FJ, van Santvoort HC, Besselink MG, Boerma D, et al. Predicting Successful Catheter Drainage in Patients With Pancreatic Fistula After Pancreatoduodenectomy. Pancreas. 2019;48(6):811-816.

Strijker M, Belkouz A, van der Geest LG, et al. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncol. 2019;58(7):1048-1055.

van Roessel S, Mackay TM, van Dieren S, van der Schelling, et al. Textbook Outcome: Nationwide Analysis of a Novel Quality Measure in Pancreatic Surgery. Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003451. [Epub ahead of print]

Mackay TM, Wellner UF, van Rijssen LB, Stoop TF, et al. Variation in pancreatoduodenectomy as delivered in two national audits. Br J Surg. 2019;106(6):747-755.

Mackay TM, van Erning FN, van der Geest LGM, de Groot JWB, et al. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis. Eur J Cancer. 2019;106:99-105.

Van Hilst J, de Rooij T, Bosscha K, Brinkman DJ, et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol Hepatol. 2019;4(3):199-207.

2018

Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG, van Eijck CHJ, et al. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg. 2018;105(8):946-958.

Zijlstra M, van der Geest LGM, van Laarhoven HWM, et al. Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands. Acta Oncol. 2018;57(9):1185-1191.

Van Erning FN, Mackay TM, van der Geest LGM, Groot Koerkamp B, et al. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis. Acta Oncol. 2018;57(12):1655-1662.

Daamen LA, Smits FJ, Besselink MG, Borel Rinkes IH, et al. Dutch Pancreatic Cancer Group. A web-based overview, systematic review and meta-analysis of pancreatic anastomosis techniques following pancreatoduodenectomy. HPB (Oxford). 2018 May. doi:10.1010/j.hpb.2018.03.003.

Strijker M, Gerritsen A, van Hilst J, et al. The Dutch Pancreas Biobank Within the Parelsnoer Institute: A Nationwide Biobank of Pancreatic and Periampullary Diseases. Pancreas. 2018;47(4):495-501.

Van Rijssen LB, Zwart MJ, Van Dieren S, et al. Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit. HPB (Oxford). 2018 Mar 20. pii: S1365-182X(18)30729-9.

Coebergh van den Braak RRJ, van Rijssen LB, van Kleef JJ, et al. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative. Acta Oncol. 2018;57(2):195-202.

de Rooij T, van Hilst J, Bosscha K, et al. Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial. Trials. 2018;3;19(1):1.

2017

Mungroop TH, van Rijssen LB, van Klaveren D, Smits FJ, et al. Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation. Ann Surg. 2017 Dec 12. doi: 10.1097 & online calculator.

Groot VP, Daamen LA, Hagendoorn J, Borel Rinkes IHM, Busch OR, van Santvoort HC, Besselink MG, Molenaar IQ; Dutch Pancreatic Cancer Group. Current Strategies for Detection and Treatment of Recurrence of Pancreatic Ductal Adenocarcinoma After Resection: A Nationwide Survey. HPB (Oxford). 2018 May. doi:10.1010/j.hpb.2018.03.003.

van der Geest LGM, Lemmens VEPP, de Hingh IHJT, van Laarhoven CJHM, Bollen TL, Nio CY, van Eijck CHJ, Busch ORC, Besselink MG; Dutch Pancreatic Cancer Group. Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer. Br J Surg. 2017 Oct;104(11):1568-1577.

van der Geest LGM, Haj Mohammad N, Besselink MGH, Lemmens VEPP, Portielje JEA, van Laarhoven HWM, Wilmink JHW; Dutch Pancreatic Cancer Group. Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer. Cancer Med. 2017 Oct 16.

van Rijssen LB, Koerkamp BG, Zwart MJ, Bonsing BA, Bosscha K, van Dam RM, et al.Dutch Pancreatic Cancer Group. Nationwide prospective audit of pancreatic surgery: design,accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. HPB (Oxford). 2017 Oct;19(10):919-926.

de Rooij T, van Hilst J, Topal B, Bosscha K, Brinkman DJ, Gerhards MF, de Hingh IH, Karsten TM, Lips DJ, Luyer MD, Marsman HA, van Rijssen LB, Steen MW, Busch OR, Festen S, Besselink MG; Dutch Pancreatic Cancer Group. Outcomes of a Multicenter Training Program in Laparoscopic Pancreatoduodenectomy (LAELAPS-2). Ann Surg. 2017 Nov 2.

Nota CL, Zwart MJ, Fong Y, Hagendoorn J, Hogg ME, Koerkamp BG, Besselink MG, Molenaar IQ; Dutch Pancreatic Cancer Group. Developing a robotic pancreas program: the Dutch experience. J Vis Surg. 2017 Aug 21.

Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the DutchPancreatic Cancer Audit. van Rijssen LB, Koerkamp BG, Zwart MJ, Bonsing BA, Bosscha K, van Dam RM, van Eijck CH, Gerhards MF, van der Harst E, de Hingh IH, de Jong KP, Kazemier G, Klaase J, van Laarhoven CJ, Molenaar IQ, Patijn GA, Rupert CG, van Santvoort HC, Scheepers JJ, van der Schelling GP, Busch OR, Besselink MG for theDutch Pancreatic Cancer Group. HPB (Oxford) 2017.

Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer. van der Geest LGM, Lemmens VEPP, de Hingh IHJT, van Laarhoven CJHM, Bollen TL, Nio CY, van Eijck CHJ, Busch ORC, Besselink MG for the Dutch Pancreatic Cancer Group. Br J Surg. 2017 Oct;104(11):1568-1577

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative. Coebergh van den Braak RRJ, van Rijssen LB, van Kleef JJ, Vink GR, Berbee M, van Berge Henegouwen MI, Bloemendal HJ, Bruno MJ, Burgmans MC, Busch ORC, Coene PPLO, Coupé VMH, Dekker JWT, van Eijck CHJ, et al. for the Dutch Pancreatic Cancer Group, Dutch Upper GI Cancer Group and PLCRC working group. Acta Oncol. 2017.

2016

• Management of severe pancreatic fistula after pancreatoduodenectomy. F.J. Smits, H.C. van Santvoort, M.G. Besselink et al. for the Dutch Pancreatic Cancer Group. JAMA Surgery. 2017 Feb [Epub ahead of print]
• DPCA Jaarrapport 2015. Dutch Pancreatic Cancer Group. https://www.dica.nl/jaarrapportage-2015/dpca.
• Impact of a Nationwide Training Program in Minimally Invasive Distal Pancreatectomy (LAELAPS). de Rooij T, van Hilst J, Boerma D et al. for the Dutch Pancreatic Cancer Group. Annals of Surgery. 2016 Aug; [Epub ahead of print]
• Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis. van Rijssen LB, Narwade P, van Huijgevoort NC, Tseng DS, van Santvoort HC, Molenaar IQ, van Laarhoven HW, van Eijck CH, Busch OR, Besselink MG; Dutch Pancreatic Cancer Group. HPB (Oxford). 2016 Jul;18(7):559-66. 
• Radiofrequente ablatie van het lokaal irresectabel pancreascarcinoom en de mogelijkheid tot een resectie na inductie chemotherapie: de PELICAN-studie. Walma MS, Rombouts SJE, Haj Mohammad N, Wilmink JW, Richel DJ, van Santvoort HC, Besselink MGH, Molenaar IQ namens de DPCG. Nederlands tijdschrift voor oncologie. 2016 Mei;13(3):91-94.
• Volume-outcome relationships in pancreatoduodenectomy for cancer. Van der Geest LGM*, van Rijssen LB*, Molenaar IQ, de Hingh IH, Groot Koerkamp B, Busch ORC, Lemmens VEPP^, Besselink MAG^. HPB (Oxford). 2016 Apr;18(4):317-24. [*^Both authors contributed equally].
• Pancreatoduodenectomy with colon resection for cancer: A nationwide retrospective analysis. Marsman EM, de Rooij T, van Eijck CH, et al. Surgery. 2016 Apr 5. [Epub ahead of print]
• Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey. Gerritsen A, Jacobs M, Henselmans I, et al. EJC. 2016 April;57:68-77.
• Pancreatic cancer surgery in elderly patients: balancing between short-term harm and long-term benefit. A population-based study in the Netherlands. Van der Geest LGM, Besselink MAG, van Gestel YRBM, Busch ORC, de Hingh IHJT, de Jong KP, Molenaar IQ, Lemmens VEPP. Acta Oncol. 2016 Mar;55(3):278-85.
• Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial. Versteijne E, van Eijck CH, Punt CJ, et al. Trials. 2016 Mar 9;17(1):127.
• Minimally invasive versus open pancreatoduodenectomy: systematic review and meta-analysis of comparative cohort and registry studies. De Rooij T, Lu MZ, Steen MW, et al. Ann Surg. 2016 Feb 10. [Epub ahead of print]
• Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis. de Rooij T, Tol JA, van Eijck CH, Voerma D, Bonsing BA, Bosscha K, van Dam RM, Dijkgraaf MG, Gerhards MF, van Goor H, vander Harst E, de Hingh IH, Kazemier G, Klaase JM, Molenaar IQ, Patijn GA, van Santvoort HC, Scheepers JJ, van der Schelling GP, Sieders E, Busch OR, Besselink MG; Dutch Pancreatic Cancer Group. Ann Surg Oncol. 2016 Feb;23(2):585-91.
• National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma. Van Rijssen LB, van der Geest LG, Bollen TL, Bruno MJ, van der Gaast A, Veerbeek L, Ten Kate FJ, Busch OR. Pancreatology. 2016 Jan-Feb;16(1):133-7.
• Elderly patients strongly benefit from centralization of pancreatic cancer surgery: A population-based study in the Netherlands. Van der Geest LGM, Besselink MAG, Busch ORC, de Hingh IHJT, van Eijck CHJ, Dejong CHC, Lemmens VEPP.Ann Surg Oncol. 2016 Jan 21. [Epub ahead of print] 2015

2015

• Outcomes of distal pancreatectomy for pancreatic ductal adenocarcinoma in the Netherlands: a nationwide retrospective analysis. de Rooij T, Tol JA, van Eijck CH, et al. Ann Surg Oncol. 2015 Oct 27. [Epub ahead of print]
• Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer. Bakens MJ, van Gestel YR, Bongers M, et al. Br J Surg. 2015 Oct 5. [Epub ahead of print]
• Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Tol JA, van Hooft JE, Timmer R, et al. Gut. 2015 Aug. pii: gutjnl-2014-308762.
• Impact of centralization of pancreatoduodenectomy on reported radical resections rates in a nationwide pathology database. Onete VG, Besselink MG, Salsbach CM, et al. HPB (Oxford). 2015 Aug;17(8):736-42.
• Diagnostic value of a pancreatic mass on computed tomography in patients undergoing pancreatoduodenectomy for presumed pancreatic cancer. Gerritsen A, Bollen TL, Nio CY, et al. Surgery. 2015 Jul;158(1):173-82.
• Feasibility and repeatability of PET with the hypoxia tracer [18F]HX4 in oesophageal and pancreatic cancer. Klaassen R, Bennink RJ, van Tienhoven G, et al. Radiother Oncol. 2015 Jul;116(1):94-9.
• Laparoscopische versus open pancreasstaart-resectie (de LEOPARD-trial). Thijs de Rooij namens de Dutch Pancreatic Cancer Group. Ned Tijdschr Geneeskd. 2015;159:A9271.
• A nationwide comparison of laparoscopic and open distal pancreatectomy for benign and malignant disease. de Rooij T, Jilesen AP, Boerma D et al. J Am Coll Surg. 2015 Mar;220(3):263-270.

 2014

• Preoperative characteristics of patients with presumed pancreatic cancer but ultimately benign disease: a multicenter series of 344 pancreatoduodenectomies. Gerritsen A, Molenaar IQ, Bollen TL, et al. Ann Surg Oncol. 2014 Nov;21(12):3999-4006.

2012

• Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg. 2012 Mar;99(3):404-10.
• Centralisatie pancreaschirurgie reduceert postoperatieve sterfte in Nederland. de Wilde RF, Besselink MG, Borel Rinkes IH, et al. Ned Tijdschr Geneeskd. 2012;156:A4791.

2011

• Abstractboek Oprichtingssymposium DPCG, nov 2011
• Audit DPCA, Medisch Contact, okt 2011